HIV/AIDS
ADVENTRX ANX-201 Abstract Accepted for Presentation at International AIDS Conference
Published in AIDS Weekly, May 7th, 2007
ADVENTRX Pharmaceuticals, Inc. (Amex: ANX), a biopharmaceutical research and development company focused on commercializing proprietary product candidates for the treatment of cancer and infectious diseases, announced today that an abstract entitled 'Synergistic antiretroviral activity of pyrophosphate analogue ANX-201 paired with nucleoside reverse transcriptase inhibitors in vitro' was accepted for presentation at the International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention. The presentation is scheduled for July 23rd. The conference takes place July 22-25, 2007 in Sydney, Australia.
About ANX-201
ANX-201...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2007-05-07)
More Articles from AIDS Weekly
- HIV/AIDS
HIV infection appears to increases the risk of heart attack - HIV/AIDS
Resistance to anti-HIV drugs in Uganda developed due to drug supply problems - HIV/AIDS
Surge in senior HIV survivors prompts new treatment studies - DNA Vaccines
VGX Pharmaceuticals Announces DNA Vaccines License Agreement with University of Pennsylvania - HIV/AIDS
Abbott Continues Drug Blacklist in Thailand, Says AIDS Healthcare Foundation - HIV/AIDS
amfAR's Trek Africa Will Educate Participants About the Reality of AIDS In Sub-Saharan Africa - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
